- Home
- PCRX vs CRML Comparison
PCRX vs CRML Comparison
Compare PCRX & CRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- CRML
- Stock Information
- Founded
- PCRX 2006
- CRML N/A
- Country
- PCRX United States
- CRML United States
- Employees
- PCRX N/A
- CRML N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- CRML
- Sector
- PCRX Health Care
- CRML
- Exchange
- PCRX Nasdaq
- CRML NYSE
- Market Cap
- PCRX 1.2B
- CRML 298.8M
- IPO Year
- PCRX 2011
- CRML N/A
- Fundamental
- Price
- PCRX $22.90
- CRML $3.00
- Analyst Decision
- PCRX Buy
- CRML
- Analyst Count
- PCRX 8
- CRML 0
- Target Price
- PCRX $28.38
- CRML N/A
- AVG Volume (30 Days)
- PCRX 545.0K
- CRML 8.0M
- Earning Date
- PCRX 07-29-2025
- CRML 02-01-2025
- Dividend Yield
- PCRX N/A
- CRML N/A
- EPS Growth
- PCRX N/A
- CRML N/A
- EPS
- PCRX N/A
- CRML N/A
- Revenue
- PCRX $702,772,000.00
- CRML $476,979.00
- Revenue This Year
- PCRX $7.54
- CRML N/A
- Revenue Next Year
- PCRX $10.78
- CRML N/A
- P/E Ratio
- PCRX N/A
- CRML N/A
- Revenue Growth
- PCRX 3.08
- CRML 326.80
- 52 Week Low
- PCRX $11.16
- CRML $1.23
- 52 Week High
- PCRX $27.64
- CRML $11.25
- Technical
- Relative Strength Index (RSI)
- PCRX 35.82
- CRML 55.25
- Support Level
- PCRX $22.82
- CRML $2.80
- Resistance Level
- PCRX $23.83
- CRML $3.34
- Average True Range (ATR)
- PCRX 0.74
- CRML 0.46
- MACD
- PCRX -0.02
- CRML -0.05
- Stochastic Oscillator
- PCRX 6.22
- CRML 42.92
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About CRML CRITICAL METALS CORPORATION
Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.